The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Safety and durability of ponatinib in patients with Philadelphia chromosome-positive (Ph+) leukemia: Long-term follow-up of an ongoing phase I study.
Michael J. Mauro
Consultant or Advisory Role - ARIAD
Research Funding - ARIAD
Jorge E. Cortes
Consultant or Advisory Role - ARIAD; Pfizer; Teva
Research Funding - ARIAD; Bristol-Myers Squibb; ChemGenex; Novartis; Pfizer
Hagop M. Kantarjian
Research Funding - ARIAD; Bristol-Myers Squibb; Bristol-Myers Squibb; Novartis; Novartis; Pfizer; Pfizer
Neil P. Shah
Consultant or Advisory Role - ARIAD
Research Funding - ARIAD; Bristol-Myers Squibb
Dale Bixby
Consultant or Advisory Role - ARIAD
Ian Flinn
Research Funding - ARIAD
Thomas O'Hare
No relevant relationships to disclose
Simin Hu
Employment or Leadership Position - ARIAD
Stock Ownership - ARIAD
Victor M. Rivera
Employment or Leadership Position - ARIAD
Stock Ownership - ARIAD
Tim Clackson
Employment or Leadership Position - ARIAD
Stock Ownership - ARIAD
Research Funding - ARIAD
Christopher D. Turner
Employment or Leadership Position - ARIAD
Stock Ownership - ARIAD
Frank G. Haluska
Employment or Leadership Position - ARIAD
Stock Ownership - ARIAD
Brian J. Druker
Consultant or Advisory Role - MolecularMD
Stock Ownership - MolecularMD
Research Funding - ARIAD
Michael W. N. Deininger
Consultant or Advisory Role - ARIAD; Bristol-Myers Squibb; Incyte; Novartis
Honoraria - ARIAD; Bristol-Myers Squibb; Incyte; Novartis
Research Funding - Bristol-Myers Squibb; Celgene; Genzyme; Gilead Sciences; Novartis
Moshe Talpaz
Consultant or Advisory Role - ARIAD
Research Funding - ARIAD